AU2003224345A8 - Antibacterial agents - Google Patents

Antibacterial agents

Info

Publication number
AU2003224345A8
AU2003224345A8 AU2003224345A AU2003224345A AU2003224345A8 AU 2003224345 A8 AU2003224345 A8 AU 2003224345A8 AU 2003224345 A AU2003224345 A AU 2003224345A AU 2003224345 A AU2003224345 A AU 2003224345A AU 2003224345 A8 AU2003224345 A8 AU 2003224345A8
Authority
AU
Australia
Prior art keywords
antibacterial agents
antibacterial
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003224345A
Other versions
AU2003224345A1 (en
Inventor
Shiv Kumar Agarwal
Surendrakumar Satyanara Pandey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Pharma Ltd
Original Assignee
Orchid Chemicals and Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals and Pharmaceuticals Ltd filed Critical Orchid Chemicals and Pharmaceuticals Ltd
Publication of AU2003224345A1 publication Critical patent/AU2003224345A1/en
Publication of AU2003224345A8 publication Critical patent/AU2003224345A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
AU2003224345A 2002-04-30 2003-04-25 Antibacterial agents Abandoned AU2003224345A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN329/MAS/2002 2002-04-30
IN329CH2002 2002-04-30
PCT/IB2003/001571 WO2003093247A2 (en) 2002-04-30 2003-04-25 Antibacterial agents

Publications (2)

Publication Number Publication Date
AU2003224345A1 AU2003224345A1 (en) 2003-11-17
AU2003224345A8 true AU2003224345A8 (en) 2003-11-17

Family

ID=29287797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003224345A Abandoned AU2003224345A1 (en) 2002-04-30 2003-04-25 Antibacterial agents

Country Status (2)

Country Link
AU (1) AU2003224345A1 (en)
WO (1) WO2003093247A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217726B2 (en) * 2002-08-22 2007-05-15 Orchid Chemicals & Pharmaceuticals Limited Antibacterial agents
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
JP2008544979A (en) 2005-06-29 2008-12-11 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Homomorpholine oxazolidinone as an antibacterial agent
WO2008090570A1 (en) * 2007-01-25 2008-07-31 Panacea Biotec Ltd Novel antimicrobials
CL2008001003A1 (en) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION.
EP3932917A3 (en) 2015-07-17 2022-03-30 The Global Alliance for TB Drug Development, Inc. Substituted phenyloxazolidinones for antimicrobial therapy
WO2017156519A1 (en) 2016-03-11 2017-09-14 The Board Of Trustees Of The University Of Illinois Small-molecules active against gram-negative bacteria
WO2018237140A1 (en) 2017-06-23 2018-12-27 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and antcancer activity
CN107382893B (en) * 2017-07-18 2020-04-28 郑州大学 Linezolid base cation amphiphilic compound with antibacterial activity and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
GB9614238D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
US6413981B1 (en) * 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
PE20020044A1 (en) * 2000-06-16 2002-01-30 Upjohn Co THIAZINE OXAZOLIDINONE
JP2004501965A (en) * 2000-06-30 2004-01-22 ファルマシア・アンド・アップジョン・カンパニー Compositions and methods for treating bacterial infections
HUP0302918A2 (en) * 2000-07-17 2003-12-29 Ranbaxy Laboratories Limited Antimicrobial oxazolidinone derivatives, and pharmaceutical compositions containing the same and process for preparation of compounds
US6951863B2 (en) * 2001-02-07 2005-10-04 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods

Also Published As

Publication number Publication date
AU2003224345A1 (en) 2003-11-17
WO2003093247A2 (en) 2003-11-13
WO2003093247A3 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003300965A8 (en) Antibacterial agents
HK1155718A1 (en) Antibacterial agents
EP1605938A4 (en) Antibacterial agents
AU2003282779A1 (en) Antibacterial agents
EP1638549A4 (en) Novel antibacterial agents
GB0207021D0 (en) Anti-bacterial agents
GB0303683D0 (en) Antimicrobial agents
GB0229673D0 (en) Antibacterial agents
AU2003224345A8 (en) Antibacterial agents
AU2003290818A8 (en) Topoisomerase-targeting agents
GB0208579D0 (en) Antibacterial agents
GB0223532D0 (en) Antibacterial agents
GB0228365D0 (en) Antibacterial agents
GB0229698D0 (en) Antibacterial agents
GB0202750D0 (en) Antibacterial agents
GB0210853D0 (en) Antibacterial agents
GB0211302D0 (en) Antibacterial agents
GB0202749D0 (en) Antibacterial agents
GB0222350D0 (en) Antibacterial agents
GB0204796D0 (en) Antibacterial agents
GB0204703D0 (en) Antibacterial agent
GB0312376D0 (en) Antibacterial agents
GB0306899D0 (en) Antibacterial agents
GB0306900D0 (en) Antibacterial agents
GB0312375D0 (en) Antibacterial agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase